|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
2001-4-3
|
|
pubmed:abstractText |
The present study investigated whether the ACAT inhibitor avasimibe can reduce atherogenesis independently of its cholesterol-lowering effect in ApoE*3-Leiden mice.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
3
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1778-86
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11282910-Acetates,
pubmed-meshheading:11282910-Animals,
pubmed-meshheading:11282910-Anticholesteremic Agents,
pubmed-meshheading:11282910-Aortic Valve,
pubmed-meshheading:11282910-Apolipoprotein E3,
pubmed-meshheading:11282910-Apolipoproteins E,
pubmed-meshheading:11282910-Arteriosclerosis,
pubmed-meshheading:11282910-Body Weight,
pubmed-meshheading:11282910-Cell Adhesion,
pubmed-meshheading:11282910-Cell Line,
pubmed-meshheading:11282910-Cholesterol,
pubmed-meshheading:11282910-Diet, Atherogenic,
pubmed-meshheading:11282910-Disease Models, Animal,
pubmed-meshheading:11282910-Eating,
pubmed-meshheading:11282910-Endothelium, Vascular,
pubmed-meshheading:11282910-Female,
pubmed-meshheading:11282910-Heterozygote,
pubmed-meshheading:11282910-Lipoproteins,
pubmed-meshheading:11282910-Macrophages,
pubmed-meshheading:11282910-Mice,
pubmed-meshheading:11282910-Mice, Transgenic,
pubmed-meshheading:11282910-Sterol O-Acyltransferase,
pubmed-meshheading:11282910-Sulfonic Acids
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice.
|
|
pubmed:affiliation |
Gaubius Laboratory, TNO-PG, Leiden, the Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
